Randomized, placebo-controlled, double-blind trial of paroxetine controlled release in irritable bowel syndrome

被引：0
作者：
Masand, PS
Patkar, AA
Dube, E
Krulewicz, S
Alamy, S
Evenden, M
Formal, M
Varia, I
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[2] Duke Univ, Med Ctr, Durham, NC 27706 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] Otilonium bromide in irritable bowel syndrome:A dose-ranging randomized double-blind placebo-controlled trial
    Danuta Chmielewska-Wilkoń
    Giorgio Reggiardo
    Colin Gerard Egan
    World Journal of Gastroenterology, 2014, (34) : 12283 - 12291
  • [22] A Randomized, Double-Blind, Placebo-Controlled Trial of St John's Wort for Treating Irritable Bowel Syndrome
    Saito, Yuri A.
    Rey, Enrique
    Almazar-Elder, Ann E.
    Harmsen, W. Scott
    Zinsmeister, Alan R.
    Locke, G. Richard
    Talley, Nicholas J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (01) : 170 - 177
  • [23] Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double-blind, placebo-controlled trial
    Seddighnia, Azadeh
    Najafabadi, Borna Tadayon
    Ghamari, Kiandokht
    Noorbala, Ahmad Ali
    Daryani, Naser Ebrahimi
    Kashani, Ladan
    Akhondzadeh, Shahin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (01) : 97 - 104
  • [24] Herbal preparations in patients with irritable bowel syndrome: Results of a double-blind, randomized, placebo-controlled multicenter trial
    Madisch, A
    Holtmann, G
    Sassin, I
    Plein, K
    Mayr, G
    Hotz, J
    GASTROENTEROLOGY, 2001, 120 (05) : A134 - A134
  • [25] A Nonviable Probiotic in Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
    Mack, Isabelle
    Schwille-Kiuntke, Juliane
    Mazurak, Nazar
    Niesler, Beate
    Zimmermann, Kurt
    Moennikes, Hubert
    Enck, Paul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1039 - +
  • [26] Kimchi improves irritable bowel syndrome: results of a randomized, double-blind placebo-controlled study
    Kim, Hee-Young
    Park, Eui-Seong
    Choi, Young Sik
    Park, Seun Ja
    Kim, Jae Hyun
    Chang, Hee Kyung
    Park, Kun-Young
    FOOD & NUTRITION RESEARCH, 2022, 66
  • [27] Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release
    Han, C.
    Masand, P. S.
    Krulewicz, S.
    Peindl, K.
    Mannelli, P.
    Varia, I. M.
    Pae, C. -U.
    Patkar, A. A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2009, 34 (01) : 79 - 88
  • [28] EFFECT OF THE COMBINATION OF BUZEPIDE METIODIDE AND HALOPERIDOL IN THE TREATMENT OF THE IRRITABLE BOWEL SYNDROME - A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL
    BARBIER, JP
    DORF, G
    GORDIN, J
    KRAINIK, F
    NEVEU, D
    PARLIER, H
    RICHARD, P
    VITAUX, J
    FRAITAG, B
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1989, 25 (03): : 123 - 128
  • [29] The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
    Shin, Seung Yong
    Cha, Bong Ki
    Kim, Won-Seok
    Park, Jae Yong
    Kim, Jeong Wook
    Choi, Chang Hwan
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 26 (01) : 117 - 127
  • [30] Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome:: A randomized, placebo-controlled, double-blind clinical trial
    Brinkhaus, B
    Hentschel, C
    Von Keudell, C
    Schindler, G
    Lindner, M
    Stützer, H
    Kohnen, R
    Willich, SN
    Lehmacher, W
    Hahn, EG
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2005, 40 (08) : 936 - 943
12345